期刊文献+

肺部给药吸收评价方法的研究进展 被引量:2

Research Progress in Absorption Evaluation Methods for Pulmonary Delivery
下载PDF
导出
摘要 目的:综述评价药物肺部吸收转运常用的方法、技术手段。方法:通过查阅Pubmed、中国知网等数据库,系统地介绍评价药物肺部吸收的体外细胞模型、离体肺泡模型和体内动物模型,并对这些模型的优缺点及其应用进行综述。结果:根据研究目的及药物的性质选择合适的肺部吸收评价模型。结论:为肺部给药制剂的研究与开发提供理论基础和研究思路。 Objective: To review the drug absorption evaluation methods for pulmonary delivery. Methods: The drug absorption cell models, in vitro pulmonary membrane model and in vivo animal model were systematically summarized, and the advantages and disadvantages of those models and applications were reviewed by referring to the databases in CNKI and Pubmed. Results: The appropriate animal model and method for the study of pulmonary absorption should be chosen according to the experimental purpose and characteristics of drugs. Conclusion: The review provides the thoughts and theoretical basis for the research and development of pulmonary delivery.
出处 《中国药师》 CAS 2016年第2期341-343,共3页 China Pharmacist
基金 国家自然科学基金项目(编号:81302705)
关键词 肺部给药 吸收评价 体外细胞模型 离体肺泡模型 体内动物模型 Pulmonary delivery Absorption evaluation In vitro cell models In vitro pulmonary membrane model In vivo animal models
  • 相关文献

参考文献29

  • 1Yang W,Peters Jl, Williams RO 3rd. Inhaled nanoparticles- a current review[ J]. Int J Pharm,2008,356(1-2 ) :239-247.
  • 2Cryan SA, Sivadas N, Garcia-Contreras L. In vivo animal models for drug delivery across the lung mucosal barrier [ J 1. Adv Drug Deliv Rev,2007,59(ll ) : 1133-1151.
  • 3Bosquillon C, Pr~at V, Vanbever R. Pulmonary delivery of growth hor- mone using dry powders and visualization of its local fate in rats[J]. Controlled Release 2004, 96 ( 2 ) :233-244.
  • 4潘锋君,吴小芬,田伟强,吕卓超.蓝芩口服液联合干扰素雾化吸入治疗小儿疱疹性咽峡炎[J].中国药师,2015,18(2):283-285. 被引量:20
  • 5平雯.细辛脑雾化吸入对毛细支气管炎患儿疗效及肺功能影响[J].中国药师,2013,16(6):875-877. 被引量:6
  • 6方芳,杨硕晔,郑剑恒,何佳珂,李宁,陈西敬,汤玥,朱家壁.应用离体牛蛙肺泡膜模型研究胰岛素的肺吸收特性[J].中国新药杂志,2011,20(12):1127-1130. 被引量:1
  • 7Wall DA, Pierdomenico D, Wilson G. An in vitro pulmonary epithelial system for evaluating peptide transport[ J]. Controlled Release, 1993, 24 ( 1-3 ) :227-235.
  • 8Yamamoto A, Tanaka H, Okumusa S,et al. Evaluation of insulin per- meability and effects of absorption enhancers on its permeability by an in vitro pulmonary epithehal system using Xenopus pulmonary mem- brane[J]. Biol Pharm Bull,2001,24(4) :385-389.
  • 9Sasai K, Sukezane T, Yanagita E, et al. Oncogene-mediated human lung epithelial cell transformation produces adenocarcinoma pheno- types in vivo[J]. Cancer Res,2011,71 (7) :2541-2549.
  • 10Sarmento B, Andrade F, da Silva SB, et al. Cell-based in vitro models for predicting drug permeability [ J ]. Expert Opin Drug Metab Toxi- col,2012,8(5) :607-621.

二级参考文献66

  • 1江煜.普米克令舒、万托林、爱全乐吸入治疗毛细支气管炎232例临床观察[J].中国医师杂志,2006,8(S1):303-304. 被引量:2
  • 2关溯,赵立子,陈杰,陈孝,黄民.Caco-2细胞模型的建立及意义[J].山东医药,2005,45(26):1-3. 被引量:10
  • 3刘瑜,吕万良,胡新,张华,张烜,王学清,张强.重组水蛭素经蟾蜍肺泡膜的转运研究[J].中国药学杂志,2005,40(17):1318-1322. 被引量:2
  • 4陈桂良,侯惠民.吸入用气雾剂雾粒测定方法的评价[J].中国医药工业杂志,2007,38(3):194-199. 被引量:24
  • 5Carina L. Peptide and protein drug delivery and the academic-industry interface[ J]. Pharm Sci Tech Today, 1998,1 (8) : 324.
  • 6Smith PL. Peptide delivery via the pulmonary route: a valid approach for local and systemic delivery[ J]. J Contr Rel, 1997,46:99.
  • 7Agu RU, Ugwoke MI, Armand M, et al. The lung as a route for systemic delivery of therapeutic proteins and peptidas[ J]. Raspir Res,2001,2(4) : 198.
  • 8Niven RW, Lott FD, IP AY, et al. Pulmonary delivery of powders and solutions containing recombinant human grannlocyte colonystimulating factor (rhG-CFS) to the rabbit[ J]. Pharm Res, 1994,11(8) : 1101.
  • 9Kobayashi S, Kondo S, Juni K. Pulmonary delivery of salmon calcitonin dry powders containing absorption enhancers in rats [ J ].Pharm Rcs,1996,13(1) : 80.
  • 10Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery [ J ]. Adv Dru Deliver Rev,2001,47(1 ) : 39.

共引文献30

同被引文献7

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部